Technology & ScienceNVIDIA Locks In Eli Lilly and Thermo Fisher as BioNeMo Becomes Global Pharma AI BackboneSalvado•May 1, 2026
Biotechnology & PharmaAmgen Merges R&D and AI Leadership as Global Pharma Embeds Generative AI Into Research StrategySalvado•Apr 30, 2026
Technology & InnovationNVIDIA Secures Thermo Fisher and Eli Lilly as Global Biotech AI Platform Race IntensifiesSalvado•Apr 29, 2026
health-technologyNVIDIA BioNeMo Platform Secures Partnerships with Eli Lilly, Thermo Fisher for AI Drug DiscoverySalvado•Apr 21, 2026
Healthcare TechnologyNVIDIA's BioNeMo Platform Powers $1.3 Trillion Pharma Industry's AI Pivot Across Three ContinentsSalvado•Apr 18, 2026
Healthcare TechnologyNVIDIA Secures Eli Lilly and Thermo Fisher for BioNeMo Drug Discovery Platform as Pharma AI Infrastructure ConsolidatesSalvado•Apr 17, 2026
HealthcareNVIDIA Captures Global Drug Discovery AI Market Through Eli Lilly, Thermo Fisher DealsSalvado•Apr 14, 2026
Health & MedicineNVIDIA's BioNeMo Platform Reaches Eli Lilly and Thermo Fisher in Global Pharma AI PushSalvado•Apr 13, 2026
biotechnologyNVIDIA BioNeMo Wins Lilly, Thermo Fisher Deals as Global Biotech AI Platform Race AcceleratesSalvado•Apr 12, 2026
HealthcareNVIDIA's BioNeMo Platform Deployed by Eli Lilly, Thermo Fisher, Six Biotech Firms for AI Drug DiscoverySalvado•Apr 11, 2026
BusinessNVIDIA Secures Thermo Fisher, Eli Lilly Partnerships for BioNeMo Drug Discovery PlatformSalvado•Apr 10, 2026
HealthNVIDIA's BioNeMo Platform Gains Pharmaceutical Industry Adoption from US to EuropeSalvado•Apr 10, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Deployed by Global Pharma Giants for AI Drug Discovery in 2026Salvado•Apr 9, 2026
health-techNVIDIA's Drug Discovery AI Platform Secures Eli Lilly, Thermo Fisher Partnerships Across Three ContinentsSalvado•Mar 29, 2026
Healthcare AINVIDIA BioNeMo Platform Secures Eli Lilly and Thermo Fisher Partnerships for AI Drug Discovery InfrastructureSalvado•Mar 26, 2026
Healthcare TechnologyNVIDIA's AI Platform Powers Drug Discovery at Thermo Fisher, Eli Lilly in $1.6 Trillion Pharma Market PushSalvado•Mar 25, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Adopted by Eli Lilly and Thermo Fisher for AI Drug DiscoverySalvado•Mar 23, 2026
BiotechNVIDIA BioNeMo Platform Gains Thermo Fisher and Eli Lilly Adoption as Biological AI Market ExpandsSalvado•Mar 22, 2026
Science & TechnologyNVIDIA's BioNeMo Aims to Become the Global Infrastructure Layer for Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Science & TechnologyNVIDIA's BioNeMo Positions AI as the New Global Lab Infrastructure in Race to Reinvent Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
